Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice
Abstract
Psychedelic drugs are poised to become mainstream treatments, yet we lack a circuit-level account of how they reshape brain activity. Emerging evidence suggests that multiple psychedelic compounds modulate activity in the brain’s default mode network (DMN), often interpreted as either increased or decreased bottom–up hierarchical processing. Most imaging studies, however, quantify activity as if it were stationary, remaining agnostic to the ascending or descending movements of activity that defines hierarchical processing. Here, we adapt optical flow analyses to track frame-to-frame trajectories of DMN activity across four independent datasets (humans and mice; methylenedioxymethamphetamine, psilocybin, and lysergic acid diethylamide; nine drug-vs.-control contrasts). In functional magnetic resonance and calcium imaging, all psychedelics attenuate signal flow magnitude and bottom–up directionality within the DMN. Propagation attenuation is not attributable to data quality or previously documented effects of psychedelics and is uniquely associated with self-reported outcomes. This replicable and generalizable attenuation of bottom–up cortical propagations provides fundamental clarification of the effects of psychedelics on macroscale hierarchical processing.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (11)
Adam R. Pines
Department of Psychiatry and Behavioral Sciences, Stanford University
Xue Zhang
John Kochalka
Department of Bioengineering, Stanford University
Sam S. Vesuna
Department of Psychiatry and Behavioral Sciences, Stanford University
Isaac V. Kauvar
Department of Bioengineering, Stanford University
Divya Rajasekharan
Department of Psychiatry and Behavioral Sciences, Stanford University
T. Rick Reneau
Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine
Teddy J. Akiki
Department of Psychiatry and Behavioral Sciences, Stanford University
Laura M. Hack
Joshua S. Siegel
Department of Psychiatry, New York University, Langone Center for Psychedelic Medicine, New York University Grossman School of Medicine
Leanne M. Williams
Department of Psychiatry and Behavioral Sciences, Stanford University